SPBC14C8.11c Antibody

What is SPBC14C8.11c and what cellular functions is it associated with?

SPBC14C8.11c is a gene in Schizosaccharomyces pombe (fission yeast) that appears to be related to genome stability pathways. Based on studies of similar proteins in the SPBC family, it may function in cellular processes involving nonsense-mediated mRNA decay (NMD) or related RNA processing mechanisms. Research involving proteins in this family has demonstrated their importance in maintaining genome stability, particularly during DNA replication and repair processes . Investigators studying SPBC14C8.11c should consider its potential role in these cellular mechanisms when designing experimental approaches for antibody-based detection and characterization.

How is an anti-SPBC14C8.11c antibody typically generated for research applications?

Anti-SPBC14C8.11c antibodies are typically generated through several established immunization protocols. For polyclonal antibodies, recombinant protein or synthetic peptide sequences unique to SPBC14C8.11c are used as immunogens in host animals (commonly rabbits). For monoclonal antibodies, hybridoma technology involving the fusion of antibody-producing B cells with myeloma cells is employed after immunizing mice with the target protein .

The process typically follows these methodological steps:

• Antigen preparation: Expression and purification of recombinant SPBC14C8.11c protein or synthesis of unique peptide sequences

• Host immunization: Following established immunization schedules with appropriate adjuvants

• Antibody harvesting: Collection of serum (polyclonal) or hybridoma selection (monoclonal)

• Purification: Affinity chromatography to isolate specific antibodies

• Validation: Testing for specificity, sensitivity, and cross-reactivity using multiple techniques

The choice between monoclonal and polyclonal antibodies depends on experimental requirements for specificity versus epitope coverage .

What are the key considerations when selecting an anti-SPBC14C8.11c antibody for experiments?

When selecting an anti-SPBC14C8.11c antibody for experimental applications, researchers should evaluate:

• Antibody specificity: Validation data demonstrating specific binding to SPBC14C8.11c without cross-reactivity to related proteins, especially other SPBC family members

• Application compatibility: Validation for specific techniques (Western blot, immunoprecipitation, ChIP, immunofluorescence)

• Species reactivity: Confirmation of reactivity with S. pombe SPBC14C8.11c, noting that antibodies may not cross-react with orthologs from other yeast species

• Epitope information: Location of the target epitope and potential interference with protein function or interactions

• Validation methodology: Comprehensive validation including negative controls and knockout validation

Additionally, researchers should consider whether the antibody recognizes specific post-translational modifications or protein conformations that may be relevant to their research questions . The validation should include appropriate controls such as SPBC14C8.11c-deficient strains to confirm specificity.

What are the optimal conditions for using anti-SPBC14C8.11c antibodies in Western blot analysis?

For optimal Western blot analysis using anti-SPBC14C8.11c antibodies, consider the following methodological parameters:

• Sample preparation:

  • Extract proteins using a yeast-specific lysis buffer containing protease inhibitors

  • Include 1-2% NP-40 or Triton X-100 for membrane protein solubilization

  • Use mechanical disruption (glass beads) for efficient yeast cell lysis

• Electrophoresis conditions:

  • 8-12% SDS-PAGE gels depending on the expected molecular weight

  • Load 20-50 μg of total protein per lane

  • Include positive and negative controls (e.g., SPBC14C8.11c-tagged strains and deletion mutants)

• Transfer parameters:

  • Semi-dry or wet transfer at 100V for 1 hour or 30V overnight

  • PVDF membranes are preferred for higher protein binding capacity

• Blocking and antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Primary antibody dilution: 1:500 to 1:2000 in blocking buffer, incubate overnight at 4°C

  • Wash buffer: TBST (TBS with 0.1% Tween-20)

  • Secondary antibody dilution: 1:5000 to 1:10000, incubate for 1 hour at room temperature

• Detection considerations:

  • Enhanced chemiluminescence (ECL) for standard detection

  • Consider fluorescent secondary antibodies for multiplex detection or quantification

Note that divalent cation dependence may affect antibody binding, similar to what has been observed with other antibodies. Therefore, using heparin instead of EDTA as an anticoagulant in sample preparation may preserve antibody-epitope interactions .

How can anti-SPBC14C8.11c antibodies be effectively used in chromatin immunoprecipitation (ChIP) experiments?

For effective ChIP experiments using anti-SPBC14C8.11c antibodies:

• Crosslinking protocol:

  • Crosslink yeast cells with 1% formaldehyde for 15-20 minutes at room temperature

  • Quench with 125 mM glycine for 5 minutes

• Chromatin preparation:

  • Lyse cells using glass bead disruption in appropriate buffer with protease inhibitors

  • Sonicate to achieve chromatin fragments of 200-500 bp (optimize sonication conditions)

  • Verify fragment size by agarose gel electrophoresis

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads for 1 hour

  • Use 2-5 μg of anti-SPBC14C8.11c antibody per reaction

  • Include appropriate controls (IgG control, input samples)

  • Incubate overnight at 4°C with rotation

• Washing and elution:

  • Perform stringent washes with increasing salt concentrations

  • Elute DNA-protein complexes with elution buffer containing SDS

  • Reverse crosslinks by incubation at 65°C overnight

• DNA purification and analysis:

  • Purify DNA using phenol-chloroform extraction or commercial kits

  • Analyze by qPCR or prepare libraries for ChIP-seq

Based on studies with similar proteins, the association of SPBC14C8.11c with chromatin may be RNA-dependent, so consider including an RNase treatment control to determine whether the interaction is direct or mediated through RNA .

What controls should be included when using anti-SPBC14C8.11c antibodies in immunoprecipitation experiments?

When performing immunoprecipitation with anti-SPBC14C8.11c antibodies, the following controls are essential:

• Input control:

  • 5-10% of the lysate used for immunoprecipitation

  • Confirms the presence of the target protein in the starting material

• Negative antibody control:

  • Non-specific IgG from the same species as the primary antibody

  • Controls for non-specific binding to beads or other components

• Genetic controls:

  • SPBC14C8.11c deletion strain lysate

  • Confirms antibody specificity and identifies non-specific bands

• Tagged protein control:

  • Lysate from strains expressing tagged SPBC14C8.11c (e.g., FLAG, HA)

  • Validates the molecular weight of the target protein

  • Can be used with tag-specific antibodies for comparison

• Competitive peptide control:

  • Pre-incubate antibody with excess immunizing peptide

  • Should abolish specific signal if antibody is specific

• Denaturing vs. native conditions:

  • Compare results under different lysis conditions

  • Helps identify specific interaction partners versus non-specific associations

The importance of these controls is emphasized by research showing that antibody validation requires multiple approaches to confirm specificity, particularly in complex systems like yeast extracts .

How can anti-SPBC14C8.11c antibodies be used to study genome stability mechanisms in S. pombe?

Anti-SPBC14C8.11c antibodies can be instrumental in investigating genome stability mechanisms in S. pombe through several sophisticated experimental approaches:

• Chromatin association dynamics:

  • Perform ChIP-seq experiments under various stress conditions (HU, MMS) to map SPBC14C8.11c binding sites

  • Analyze association with replication origins, transcriptionally active regions, or sites of DNA damage

  • Compare binding profiles between wild-type and mutant strains defective in DNA replication or repair

• Protein complex identification:

  • Use antibodies for co-immunoprecipitation followed by mass spectrometry

  • Identify interaction partners in different cell cycle phases or following genotoxic stress

  • Compare protein complexes under normal conditions versus replication stress

• Cell cycle-dependent localization:

  • Perform immunofluorescence across synchronized cell populations

  • Correlate localization patterns with cell cycle progression markers

  • Examine redistribution following DNA damage or replication fork stalling

• Post-translational modification analysis:

  • Use phospho-specific antibodies or general anti-SPBC14C8.11c antibodies followed by phosphatase treatment

  • Identify conditions that trigger modification (e.g., DNA damage response activation)

  • Correlate modifications with functional changes

Based on studies with related proteins like Upf1, investigate potential involvement in nonsense-mediated mRNA decay pathways and their intersection with genome stability mechanisms, particularly during S-phase or in response to replication inhibitors .

What approaches can be used to determine if SPBC14C8.11c has RNA-dependent chromatin association?

To investigate whether SPBC14C8.11c exhibits RNA-dependent chromatin association, researchers can employ several methodological approaches:

• RNase treatment experiments:

  • Perform ChIP with or without RNase treatment of chromatin preparations

  • Compare binding profiles to identify RNase-sensitive binding sites

  • Include controls with RNase inhibitors to confirm specificity

• RNA immunoprecipitation (RIP):

  • Use anti-SPBC14C8.11c antibodies to precipitate protein-RNA complexes

  • Analyze associated RNAs by RT-qPCR or RNA-seq

  • Compare with CLIP-seq (crosslinking immunoprecipitation) to identify direct RNA interactions

• Genetic approaches:

  • Analyze SPBC14C8.11c chromatin association in strains defective for RNA processing factors

  • Create SPBC14C8.11c mutants defective in putative RNA-binding domains

  • Perform epistasis analysis with RNA processing pathway components

• Proximity ligation assays:

  • Use antibodies against SPBC14C8.11c and RNA polymerase II

  • Determine co-localization at sites of active transcription

  • Compare signals with and without RNase treatment

Based on findings with similar proteins, SPBC14C8.11c may associate with both protein-coding and non-protein-coding genes, with this association potentially being RNA-dependent. This should be systematically investigated using the approaches outlined above .

How can synthetic genetic interactions be used to understand SPBC14C8.11c function?

Synthetic genetic interaction analysis provides powerful insights into SPBC14C8.11c function through the following methodological approaches:

• Systematic genetic screens:

  • Perform synthetic genetic array (SGA) analysis crossing SPBC14C8.11c deletion with genome-wide deletion libraries

  • Identify synthetic sick or lethal interactions suggesting functional relationships

  • Use quantitative fitness analysis to measure interaction strengths

• Targeted epistasis analysis:

  • Test genetic interactions with genes involved in specific pathways (e.g., DNA replication, repair, RNA processing)

  • Create double mutants using tetrad dissection or plasmid shuffling techniques

  • Perform growth assays under various stress conditions (temperature, genotoxins)

• Chemical-genetic profiling:

  • Test sensitivity of SPBC14C8.11c mutants to compounds affecting specific pathways

  • Compare chemical genetic profiles with known pathway mutants

  • Identify conditions that enhance phenotypes of SPBC14C8.11c mutants

• High-content screening:

  • Use fluorescent reporters to monitor cellular processes in SPBC14C8.11c mutant backgrounds

  • Quantify phenotypes using automated microscopy and image analysis

  • Identify genetic backgrounds that modify SPBC14C8.11c-associated phenotypes

Based on studies with related proteins, SPBC14C8.11c may exhibit synthetic interactions with genes involved in genome stability, particularly those functioning in homologous recombination (e.g., rad52) or RNA processing pathways (e.g., air1, ppn1). These interactions are often enhanced under conditions of replication stress or temperature sensitivity .

What are common issues when using anti-SPBC14C8.11c antibodies and how can they be resolved?

Researchers commonly encounter several challenges when working with anti-SPBC14C8.11c antibodies. Here are methodological solutions to these issues:

• High background in Western blots:

  • Increase blocking time/concentration (try 5% BSA instead of milk)

  • Reduce primary antibody concentration (perform titration series)

  • Increase wash duration and number of washes (4-5 washes, 10 minutes each)

  • Try alternative blocking agents (casein, commercial blockers)

  • Use more stringent wash buffers (increase Tween-20 to 0.2%)

• Weak or no signal detection:

  • Optimize protein extraction method for S. pombe (use glass bead lysis)

  • Check protein transfer efficiency (use stained molecular weight markers)

  • Increase protein loading (50-100 μg per lane)

  • Decrease antibody dilution (1:250 - 1:500)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use more sensitive detection systems (high-sensitivity ECL substrates)

• Multiple bands or unexpected molecular weight:

  • Verify expected molecular weight based on protein sequence

  • Include positive controls (tagged version of SPBC14C8.11c)

  • Check for post-translational modifications or degradation products

  • Use freshly prepared samples with complete protease inhibitor cocktails

  • Consider denaturing conditions that may affect epitope accessibility

• Poor immunoprecipitation efficiency:

  • Optimize lysis conditions (test different detergents and salt concentrations)

  • Pre-clear lysates thoroughly to reduce non-specific binding

  • Cross-link antibody to beads to prevent antibody contamination in eluates

  • Increase antibody amount or incubation time

  • Consider using tagged SPBC14C8.11c if native antibody performance is suboptimal

• Inconsistent ChIP results:

  • Optimize crosslinking time (too little or too much can reduce efficiency)

  • Verify sonication efficiency by checking DNA fragment size

  • Include spike-in controls for normalization

  • Consider divalent cation dependency similar to other antibodies

What is the best approach for validating the specificity of anti-SPBC14C8.11c antibodies?

A comprehensive validation strategy for anti-SPBC14C8.11c antibodies should include:

• Genetic validation:

  • Compare signal between wild-type and SPBC14C8.11c deletion strains

  • Test in strains with varying expression levels (e.g., under inducible promoters)

  • Analyze signal in strains expressing truncated versions of the protein

• Tagged protein controls:

  • Generate strains expressing epitope-tagged SPBC14C8.11c (FLAG, HA, GFP)

  • Perform parallel detection with tag-specific antibodies

  • Confirm co-localization of signals in immunofluorescence studies

• Competitive inhibition assays:

  • Pre-incubate antibody with immunizing peptide or recombinant protein

  • Verify signal reduction in all applications

  • Use titration of competing antigen to demonstrate specificity

• Orthogonal detection methods:

  • Compare results across multiple techniques (Western blot, IF, IP, ChIP)

  • Consistent results across methods increase confidence in specificity

  • Different techniques may reveal context-dependent specificity issues

• Mass spectrometry validation:

  • Perform IP followed by mass spectrometry

  • Confirm presence of SPBC14C8.11c peptides in immunoprecipitates

  • Identify potential cross-reactive proteins

This multi-faceted approach is critical because antibody specificity can vary across applications and experimental conditions, requiring thorough validation for each specific use case .

How can I develop a quantitative assay to measure SPBC14C8.11c levels in yeast extracts?

To develop a robust quantitative assay for SPBC14C8.11c in yeast extracts, consider these methodological approaches:

• Quantitative Western blotting:

  • Use fluorescent secondary antibodies for linear detection range

  • Include recombinant protein standards at known concentrations

  • Apply housekeeping protein normalization (e.g., tubulin, actin)

  • Analyze using digital imaging software with standard curve fitting

  • Validate linearity across expected concentration range

• ELISA development:

  • Coat plates with capture antibody (anti-SPBC14C8.11c)

  • Develop standard curve using recombinant protein

  • Use a detection antibody targeting a different epitope

  • Optimize blocking and wash conditions for yeast extracts

  • Validate with spike-in experiments (known amounts added to extracts)

• Immunoprecipitation-based quantification:

  • Perform quantitative IP with standardized antibody amounts

  • Use isotope-labeled reference peptides for mass spectrometry quantification

  • Compare target peptide abundance to reference standards

  • Account for IP efficiency using calibration curves

• Flow cytometry for intact cells:

  • Optimize fixation and permeabilization for intracellular staining

  • Use fluorophore-conjugated anti-SPBC14C8.11c antibodies

  • Include calibration beads with known fluorophore numbers

  • Convert fluorescence intensity to molecules per cell

For therapeutic antibody detection applications, consider techniques that specifically distinguish between total, activated, and antigen-conjugated antibodies, as these different forms may provide important functional information .

How should ChIP-seq data for SPBC14C8.11c be analyzed and interpreted?

Analyzing and interpreting ChIP-seq data for SPBC14C8.11c requires a comprehensive computational approach:

• Data preprocessing:

  • Quality control using FastQC to assess sequencing quality

  • Adapter trimming and quality filtering with tools like Trimmomatic

  • Alignment to S. pombe genome using Bowtie2 or BWA

  • Remove PCR duplicates using Picard MarkDuplicates

  • Generate normalized coverage tracks (bigWig format)

• Peak calling:

  • Use MACS2 with appropriate parameters for transcription factor-like binding

  • Include input DNA control for background normalization

  • Consider IDR (Irreproducible Discovery Rate) analysis if replicate experiments are available

  • Define stringent thresholds for peak calling (q-value < 0.01)

• Genomic feature analysis:

  • Annotate peaks relative to genomic features (promoters, gene bodies, terminators)

  • Perform motif discovery using MEME-ChIP or similar tools

  • Analyze peak distribution across the genome (e.g., proximity to transcription start sites)

  • Compare binding sites with known functional elements (origins, centromeres)

• Comparative analysis:

  • Compare binding profiles under different conditions (normal vs. stressed)

  • Integrate with transcriptome data to correlate binding with expression

  • Compare with other chromatin-associated factors (RNA polymerase, chromatin modifiers)

  • Identify condition-specific binding sites

• Data visualization and interpretation:

  • Generate heatmaps and average profile plots centered on genomic features

  • Use genome browsers (IGV, JBrowse) for detailed visualization

  • Perform clustering analysis to identify binding patterns

  • Consider RNA-dependence of binding based on RNase treatment experiments

Based on research with related proteins, analyze binding patterns in relation to actively transcribed genes and sites of DNA replication or repair, as SPBC14C8.11c may associate with both protein-coding and non-protein-coding genes in an RNA-dependent manner .

How can I interpret synthetic genetic interaction data involving SPBC14C8.11c?

Interpreting synthetic genetic interaction data for SPBC14C8.11c requires systematic analysis to derive meaningful biological insights:

• Network construction and analysis:

  • Build an interaction network with SPBC14C8.11c and its genetic interactors

  • Apply network clustering algorithms to identify functional modules

  • Calculate network statistics (degree, betweenness centrality) to identify key nodes

  • Compare with published genetic interaction networks for related genes

• Pathway enrichment analysis:

  • Perform Gene Ontology enrichment analysis on genetic interactors

  • Identify overrepresented biological processes, molecular functions, or cellular components

  • Use pathway databases (KEGG, Reactome) to map interactors to known pathways

  • Look for enrichment of specific complexes or functional groups

• Condition-dependent interaction interpretation:

  • Analyze how interactions change under different conditions (temperature, genotoxic stress)

  • Identify stress-specific interactions that suggest conditional functions

  • Compare interaction strength across conditions using quantitative fitness measurements

  • Look for suppressors versus enhancers of phenotypes

• Integration with physical interaction data:

  • Compare genetic interactions with known physical interaction networks

  • Identify cases where genetic interactions reflect direct physical associations

  • Look for "between-pathway" versus "within-pathway" genetic interactions

  • Use genetic interaction patterns to predict physical interaction partners

Based on studies with related proteins, pay particular attention to interactions with genes involved in DNA replication (PCNA modification), homologous recombination (rad52), and RNA processing pathways (air1, ppn1), as these may reveal functions in maintaining genome stability during DNA replication and repair processes .

What are the latest methodologies for studying SPBC14C8.11c interactions with RNA and chromatin simultaneously?

Cutting-edge methodologies for investigating SPBC14C8.11c interactions with both RNA and chromatin include:

• CLIP-seq combined with ChIP-seq:

  • Perform parallel CLIP-seq and ChIP-seq experiments

  • Identify regions where RNA binding and chromatin association overlap

  • Develop computational pipelines to integrate both datasets

  • Map RNA-mediated chromatin interactions at high resolution

• Proximity ligation approaches:

  • Apply RNA-DNA proximity ligation assays using SPBC14C8.11c as a bridge

  • Identify RNA-DNA contacts mediated by SPBC14C8.11c

  • Use Hi-C approaches to map chromatin interactions dependent on SPBC14C8.11c

  • Employ Chromatin Isolation by RNA Purification (ChIRP) to identify RNA-chromatin interactions

• Live-cell imaging techniques:

  • Generate fluorescently tagged SPBC14C8.11c

  • Use RNA-binding dyes or MS2-tagged RNAs for co-visualization

  • Apply super-resolution microscopy to resolve molecular interactions

  • Perform FRAP (Fluorescence Recovery After Photobleaching) to measure dynamic associations

• Mass spectrometry approaches:

  • Use APEX or BioID proximity labeling to identify proteins near SPBC14C8.11c in vivo

  • Perform RNA-protein crosslinking followed by mass spectrometry

  • Identify post-translational modifications dependent on RNA binding

  • Apply ChIP-SICAP (Selective Isolation of Chromatin-Associated Proteins) for complexes

These advanced methodologies build upon foundational techniques while providing integrated views of SPBC14C8.11c's dual interactions with RNA and chromatin, which may be critical for understanding its role in genome stability and RNA processing pathways .

How might SPBC14C8.11c function in the context of S-phase and genome stability?

Based on studies with related proteins, SPBC14C8.11c likely plays important roles in S-phase progression and genome stability through several potential mechanisms:

• Replication fork stability:

  • May associate with active replication forks during S-phase

  • Could function in resolving RNA:DNA hybrids (R-loops) at transcription-replication conflict sites

  • Might coordinate RNA processing with DNA replication to prevent genome instability

  • Could influence PCNA modification states during replication stress

• Checkpoint signaling:

  • May participate in S-phase checkpoint activation or recovery

  • Could affect cell cycle progression when DNA replication is challenged

  • Might influence checkpoint protein abundance through RNA processing functions

  • May be regulated by checkpoint-dependent phosphorylation

• Homologous recombination:

  • Could affect expression of homologous recombination factors like Rad52

  • Might directly participate in resolving replication-associated DNA damage

  • May influence recombination-mediated fork restart after replication stress

  • Could function in the non-coding RNA regulation of recombination processes

• RNA-mediated genome stability:

  • Potential role in co-transcriptional RNA processing to prevent R-loop formation

  • May influence chromatin states at transcriptionally active regions

  • Could coordinate transcription termination with DNA replication

  • Might regulate non-coding RNAs involved in genome stability

Studies with related proteins have shown hypersensitivity to DNA replication inhibitors like hydroxyurea and methyl methanesulfonate, delayed S-phase progression, and synthetic genetic interactions with homologous recombination factors, suggesting SPBC14C8.11c may function at the intersection of RNA metabolism and DNA replication processes .

What are the remaining gaps in our understanding of SPBC14C8.11c function?

Despite significant progress in understanding proteins similar to SPBC14C8.11c, several critical knowledge gaps remain:

• Direct biochemical activities:

  • The precise enzymatic or structural functions remain undefined

  • RNA binding specificity and affinity measurements are needed

  • ATP-dependent activities (if any) have not been characterized

  • Structural information about protein domains and their functions is limited

• Regulatory mechanisms:

  • Cell cycle-dependent regulation remains poorly understood

  • Post-translational modifications and their functional consequences

  • Upstream regulators controlling activity or localization

  • Condition-specific activation or repression mechanisms

• Integration with cellular pathways:

  • Precise positioning within RNA processing pathways

  • Direct versus indirect effects on genome stability

  • Integration with cell cycle checkpoints

  • Coordination with DNA replication and repair machineries

• Evolutionary conservation of function:

  • Functional conservation between yeast and higher eukaryotes

  • Specialization of function in different organisms

  • Identification of functional orthologs in other species

  • Conservation of regulatory mechanisms

Addressing these knowledge gaps will require integrative approaches combining genetic, biochemical, and high-throughput methods to fully elucidate the functions of SPBC14C8.11c in cellular processes and genome maintenance .

What future experimental approaches will advance our understanding of SPBC14C8.11c?

Future experimental directions to advance our understanding of SPBC14C8.11c should include:

• CRISPR-based functional genomics:

  • Generate domain-specific mutations to dissect protein function

  • Perform genome-wide screens for genetic interactions using CRISPR

  • Apply CRISPRi for temporal control of expression

  • Use CRISPR activation/repression to identify regulatory relationships

• Single-molecule approaches:

  • Apply single-molecule RNA tracking in live cells

  • Use optical tweezers to measure RNA-protein interactions

  • Perform single-molecule FRET to study conformational changes

  • Apply zero-mode waveguides for real-time enzyme kinetics

• Structural biology integration:

  • Determine high-resolution structures using cryo-EM

  • Map functional domains through hydrogen-deuterium exchange mass spectrometry

  • Use integrative structural biology combining multiple data types

  • Apply AlphaFold predictions with experimental validation

• Systems biology frameworks:

  • Develop comprehensive mathematical models of SPBC14C8.11c function

  • Perform multi-omics integration (transcriptomics, proteomics, metabolomics)

  • Use network analysis to position SPBC14C8.11c within cellular pathways

  • Apply machine learning to predict condition-specific functions

• Translational relevance exploration:

  • Identify human orthologs and their disease associations

  • Explore therapeutic targeting strategies if relevant to human disease

  • Investigate conservation of genome stability mechanisms

  • Apply knowledge to improve biotechnological applications